Late cardiopulmonary toxicity after treatment for Hodgkin's disease
1992

Cardiopulmonary Effects of Hodgkin's Disease Treatment

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): C. Allavena, T. Conroy, P. Aletti, P. Bey, P. Lederlin

Primary Institution: Centre Alexis Vautrin

Hypothesis

What is the impact of mantle field irradiation techniques on long-term cardiopulmonary function in Hodgkin's disease survivors?

Conclusion

Mantle field radiotherapy for Hodgkin's disease results in minimal long-term cardiopulmonary dysfunction.

Supporting Evidence

  • Only 16% of chest radiographs showed moderate or severe abnormalities.
  • 64% of patients had reduced lung perfusion in irradiated areas without symptoms.
  • Patients showed significantly lower Total Capacity and Vital Capacity compared to a control group.

Takeaway

Doctors looked at how treatment for Hodgkin's disease affects the heart and lungs years later, and found that most patients had very few problems.

Methodology

Patients were evaluated for cardiac and pulmonary functions using various tests including ECG, echocardiography, pulmonary function tests, and Xenon scintigraphy.

Limitations

The follow-up period was relatively short, and the study may not capture all long-term effects.

Participant Demographics

75 patients aged 19 to 49 years, with a mean age of 34 years; 49 males and 26 females.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication